tiprankstipranks
Top Stocks
U.S. Stock Market OverviewTop Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
Top ETFs by AUMSPY ETFQQQ ETF
Stock Comparison
Energy StocksOil StocksBest Value StocksAirline StocksElectric Vehicle StocksMATANA Stocks
New
Bank StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
Global Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsPre-Market BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsTools for Trading PlatformsData for Hedge FundsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Top ETFs by AUM
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
U.S. Markets
Market Movers
Expert Center
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
Top ETFs by AUM
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Energy Stocks
EV Stocks
Crypto News
Dividend Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Pre-Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

HAE Stock Latest News

Haemonetics price target raised to $110 from $100 at Mizuho
The FlyHaemonetics price target raised to $110 from $100 at Mizuho
2d ago
HAE
ViewRay CFO to step down, William Burke to succeed
The FlyViewRay CFO to step down, William Burke to succeed
17d ago
HAE
VRAY
Haemonetics management to meet virtually with JMP Securities
The FlyHaemonetics management to meet virtually with JMP Securities
1M ago
HAE
Haemonetics management to meet with Mizuho
The FlyHaemonetics management to meet with Mizuho
1M ago
HAE
Haemonetics management to meet with Mizuho
The FlyHaemonetics management to meet with Mizuho
1M ago
HAE
Haemonetics price target raised to $92 from $88 at Citi
The FlyHaemonetics price target raised to $92 from $88 at Citi
2M ago
HAE
Haemonetics management to meet virtually with JMP Securities
The FlyHaemonetics management to meet virtually with JMP Securities
2M ago
HAE
Haemonetics 2nd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
Press ReleasesHaemonetics 2nd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
3M ago
HAE
Haemonetics 1st Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
Press ReleasesHaemonetics 1st Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
6M ago
HAE
Haemonetics Systems in Demand, Shares Discounted
Stock Analysis & IdeasHaemonetics Systems in Demand, Shares Discounted
10M ago
HAE
Haemonetics Stock: Valuation Is Low, Analysts Expect Upside
Stock Analysis & IdeasHaemonetics Stock: Valuation Is Low, Analysts Expect Upside
1y ago
HAE
Haemonetics Stock: Attractive Price, Decent Financials
Stock Analysis & IdeasHaemonetics Stock: Attractive Price, Decent Financials
1y ago
HAE
Haemonetics Exceeds Q1 Expectations; Shares Jump 7.4%
Market NewsHaemonetics Exceeds Q1 Expectations; Shares Jump 7.4%
1y ago
HAE
Haemonetics: Is This Pharma Stock A Hidden Gem?
Stock Analysis & IdeasHaemonetics: Is This Pharma Stock A Hidden Gem?
2y ago
HAE
3 Stocks Trading at Rock-Bottom Prices; Analysts Say ‘Buy’
Stock Analysis & Ideas3 Stocks Trading at Rock-Bottom Prices; Analysts Say ‘Buy’
2y ago
EBS
HAE
Raymond James: These 3 Stocks Have Over 100% Upside on the Horizon
Stock Analysis & IdeasRaymond James: These 3 Stocks Have Over 100% Upside on the Horizon
2y ago
HAE
LABP
tipranks
TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions.
Find Us on
twitterstocktwitsfacebooklinkedininstagram
Newsletter SubscriptionEnter your email to receive our newsletter
iosandroid
SitemapTerms of UsePrivacy PolicyFAQ
Research ToolsTop Smart Score StocksTrending StocksDaily Stock RatingsStock ScreenerStock ComparisonAnalysts' Top StocksDaily Insider TransactionsInsiders' Hot StocksExpert Center
CalendarsEarnings CalendarDividend CalendarIPO CalendarStock Market Holidays
EducationGlossaryTipRanks Labs
PlansPlans & PricingAPI for Institutions
CompanyAbout TipRanksContact UsReviews
Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.